Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1979 Feb;7(2):201–206. doi: 10.1111/j.1365-2125.1979.tb00922.x

Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs.

E Perucca, A Richens
PMCID: PMC1429435  PMID: 760753

Abstract

1 The serum concentration profile of paracetamol has been determined after administration of single 1000 mg intravenous and oral doses in six normal subjects and six epileptic patients on chronic antiepileptic drug therapy. The urinary excretion of free and conjugated paracetamol has also been determined. 2 Following intravenous administration, serum paracetamol concentration declined with first-order kinetics. Both elimination rate and total body clearance were higher in the epileptic patients, although in neither case was the difference statistically significant. 3 The oral bioavailability (mean +/- s.e. mean) was significantly lower in the epileptic patients than in the normal subjects (0.77 +/- 0.03 and 0.89 +/- 0.02 respectively, P less than 0.01), whereas the urinary excretion total (free+conjugated) paracetamol was almost identical in the two groups. 4 It is suggested that the lower bioavailability of paracetamol in the epileptic patients results from enhancement of first-pass metabolism, secondary to enzyme induction.

Full text

PDF
201

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alván G., Piafsky K., Lind M., von Bahr C. Effect of pentobarbital on the disposition of alprenolol. Clin Pharmacol Ther. 1977 Sep;22(3):316–321. doi: 10.1002/cpt1977223316. [DOI] [PubMed] [Google Scholar]
  2. Blaschke T. F., Berk P. D., Rodkey F. L., Scharschmidt B. F., Collison H. A., Waggoner J. G. Drugs and the liver. I. Effects of glutethimide and phenobarbital on hepatic bilirubin clearance, plasma bilirubin turnover and carbon monoxide production in man. Biochem Pharmacol. 1974 Oct 15;23(20):2795–2806. doi: 10.1016/0006-2952(74)90053-7. [DOI] [PubMed] [Google Scholar]
  3. Branch R. A., Shand D. G., Wilkinson G. R., Nies A. S. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow. J Clin Invest. 1974 Apr;53(4):1101–1107. doi: 10.1172/JCI107647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Breckenridge A. Clinical implications of enzyme induction. Basic Life Sci. 1975;6:273–301. doi: 10.1007/978-1-4615-8954-9_9. [DOI] [PubMed] [Google Scholar]
  5. Conney A. H. Pharmacological implications of microsomal enzyme induction. Pharmacol Rev. 1967 Sep;19(3):317–366. [PubMed] [Google Scholar]
  6. Cummings A. J., King M. L., Martin B. K. A kinetic study of drug elimination: the excretion of paracetamol and its metabolites in man. Br J Pharmacol Chemother. 1967 Feb;29(2):150–157. doi: 10.1111/j.1476-5381.1967.tb01948.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Davis M., Simmons C. J., Harrison N. G., Williams R. Paracetamol overdose in man: relationship between pattern of urinary metabolites and severity of liver damage. Q J Med. 1976 Apr;45(178):181–191. [PubMed] [Google Scholar]
  8. Gibaldi M., Boyes R. N., Feldman S. Influence of first-pass effect on availability of drugs on oral administration. J Pharm Sci. 1971 Sep;60(9):1338–1340. doi: 10.1002/jps.2600600909. [DOI] [PubMed] [Google Scholar]
  9. Koch-Weser J. Drug therapy. Acetaminophen. N Engl J Med. 1976 Dec 2;295(23):1297–1300. doi: 10.1056/NEJM197612022952306. [DOI] [PubMed] [Google Scholar]
  10. Kuntzman R. Drugs and enzyme induction. Annu Rev Pharmacol. 1969;9:21–36. doi: 10.1146/annurev.pa.09.040169.000321. [DOI] [PubMed] [Google Scholar]
  11. Lecamwasam D. S. Hepatic enzyme induction and its relationship to urinary D-glucaric acid excretion in man. Br J Clin Pharmacol. 1975 Dec;2(6):546–548. doi: 10.1111/j.1365-2125.1975.tb00576.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lowenthal D. T., Oie S., Van Stone J. C., Briggs W. A., Levy G. Pharmacokinetics of acetaminophen elimination by anephric patients. J Pharmacol Exp Ther. 1976 Mar;196(3):570–578. [PubMed] [Google Scholar]
  13. McLean A. E., Day P. A. The effect of diet on the toxicity of paracetamol and the safety of paracetamol-methionine mixtures. Biochem Pharmacol. 1975 Jan 1;24(1):37–42. doi: 10.1016/0006-2952(75)90310-x. [DOI] [PubMed] [Google Scholar]
  14. Mitchell J. R., Potter W. Z. Drug metabolism in the production of liver injury. Med Clin North Am. 1975 Jul;59(4):877–885. doi: 10.1016/s0025-7125(16)31986-1. [DOI] [PubMed] [Google Scholar]
  15. Mrochek J. E., Katz S., Christie W. H., Dinsmore S. R. Acetaminophen metabolism in man, as determined by high-resolution liquid chromatography. Clin Chem. 1974 Aug;20(8):1086–1096. [PubMed] [Google Scholar]
  16. Nies A. S., Wilkinson G. R., Rush B. D., Strother J. R., McDevitt D. G. Effects of alteration of hepatic microsomal enzyme activity on liver blood flow in the rat. Biochem Pharmacol. 1976 Sep 1;25(17):1991–1993. doi: 10.1016/0006-2952(76)90055-1. [DOI] [PubMed] [Google Scholar]
  17. Odar-Cederlöf I., Borgå O. Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding. Eur J Clin Pharmacol. 1974;7(1):31–37. doi: 10.1007/BF00614387. [DOI] [PubMed] [Google Scholar]
  18. Ohnhaus E. E., Thorgeirsson S. S., Davies D. S., Breckenridge A. Changes in liver blood flow during enzyme induction. Biochem Pharmacol. 1971 Oct;20(10):2561–2570. doi: 10.1016/0006-2952(71)90164-x. [DOI] [PubMed] [Google Scholar]
  19. Perrier D., Gibaldi M. Clearance and biologic half-life as indices of intrinsic hepatic metabolism. J Pharmacol Exp Ther. 1974 Oct;191(1):17–24. [PubMed] [Google Scholar]
  20. Prescott L. F. Gas-liquid chromatographic estimation of paracetamol. J Pharm Pharmacol. 1971 Oct;23(10):807–808. doi: 10.1111/j.2042-7158.1971.tb08613.x. [DOI] [PubMed] [Google Scholar]
  21. Prescott L. F. The gas-liquid chromatographic estimation of phenacetin and paracetamol in plasma and urine. J Pharm Pharmacol. 1971 Feb;23(2):111–115. doi: 10.1111/j.2042-7158.1971.tb08622.x. [DOI] [PubMed] [Google Scholar]
  22. Rawlins M. D., Henderson D. B., Hijab A. R. Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration. Eur J Clin Pharmacol. 1977 Apr 20;11(4):283–286. doi: 10.1007/BF00607678. [DOI] [PubMed] [Google Scholar]
  23. Redinger R. N., Small D. M. Primate biliary physiology. 8. The effect of phenobarbital upon bile salt synthesis and pool size, biliary lipid secretion, and bile composition. J Clin Invest. 1973 Jan;52(1):161–172. doi: 10.1172/JCI107160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Reyes H., Levi A. J., Gatmaitan Z., Arias I. M. Studies of Y and Z, two hepatic cytoplasmic organic anion-binding proteins: effect of drugs, chemicals, hormones, and cholestasis. J Clin Invest. 1971 Nov;50(11):2242–2252. doi: 10.1172/JCI106721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rowland M. Influence of route of administration on drug availability. J Pharm Sci. 1972 Jan;61(1):70–74. doi: 10.1002/jps.2600610111. [DOI] [PubMed] [Google Scholar]
  26. Shively C. A., Vesell E. S. Temporal variations in acetaminophen and phenacetin half-life in man. Clin Pharmacol Ther. 1975 Oct;18(4):413–424. doi: 10.1002/cpt1975184413. [DOI] [PubMed] [Google Scholar]
  27. Triggs E. J., Nation R. L., Long A., Ashley J. J. Pharmacokinetics in the elderly. Eur J Clin Pharmacol. 1975;8(1):55–62. doi: 10.1007/BF00616415. [DOI] [PubMed] [Google Scholar]
  28. Wilkinson G. R., Shand D. G. Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther. 1975 Oct;18(4):377–390. doi: 10.1002/cpt1975184377. [DOI] [PubMed] [Google Scholar]
  29. Wrights N., Prescott L. F. Potentiation by previous drug therapy of hepatotoxicity following paracetamol overdosage. Scott Med J. 1973 Mar;18(2):56–58. doi: 10.1177/003693307301800205. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES